Let's talk medical research

Making use of electronic patient-reported outcomes (otherwise known as ePRO) can provide a streamlined way to offer a more patient-centric experience and reduce the burden of site staff. Modern ePRO vendors can provide a range of features for clinical trial participants, communicate seamlessly with Interactive Web Response Systems, and provide support services throughout the trial.

We’re excited to share that we’ll be in attendance for the 15th annual SCOPE conference! The conference takes place in Orlando, Florida from February 11th to 14th, and will bring together some of the top companies in the clinical ops industry today.

Endometrial cancer, also known as endometrial carcinoma or uterine cancer, is a condition that approximately 66,000 individuals are diagnosed with annually, and instances rise roughly 2% in the United States each year. Because it is often caught early, a person’s prognosis is typically good — but it is still a disheartening diagnosis that significantly impacts the lives of those who experience it.

Facilitating medical research relies on patient participation, yet research protocols often overlook the patient perspective. Improving patient centricity in clinical trials demands prioritizing the patient experience.

For individuals living with a condition like melanoma, volunteering to participate in a clinical trial can be a rewarding experience. Not only will patients be able to gain access to potential new treatments, but they will also be directly contributing to research that can save lives — something that Jamie Troil Goldfarb has experienced firsthand. Jamie received a diagnosis of stage IV melanoma ...

Colorectal cancer (often shortened simply to colon cancer) is the fourth-most commonly diagnosed cancer in the United States, and it is estimated that around 150,000 Americans are diagnosed each year. While the average age of diagnosis is 66, young adults are getting diagnosed in higher numbers every year, and researchers are still unsure as to why.

Recruiting patients for clinical trials is a common challenge for study sponsors conducting research. For this reason, it is often a wise strategy to work with an agency that specializes in outreach. These agencies excel at helping sponsors achieve their research goals within defined timelines and budgets.

Multiple sclerosis, often shortened to MS, is an autoimmune disorder that causes the body to attack the central nervous system. It is estimated that a million adults in the United States are living with this condition, and symptoms can include a variety of phenomena such as numbness, tingling, speech difficulties, tremors, vision issues, balance problems, and pain, all at varying degrees of ...

Volunteers play a vital role in clinical trials; nevertheless, the participant experience is often suboptimal. In an interview with Newsweek, Paul Wicks, former VP of Innovation at PatientsLikeMe once remarked, “Sometimes, it’s almost as bad as dealing with Comcast or the worst airline.” When patients are faced with overwhelming paperwork, inconvenient appointment times, and tedious symptom ...

Antidote’s mission is to connect patients with medical research so medical breakthroughs can take place. A key part of our strategy is partnering with nonprofits and patient advocacy groups. We provide our clinical trial matching technology, Antidote Match, at no cost to these organizations, to help patients and caregivers discover new research opportunities and connect to clinical trials quickly ...